Companies: 49,246 Total Market Cap: 132591774254860.43

Divi's Laboratories Limited

NSE-DIVISLAB
Healthcare Drug Manufacturers - Specialty & Generic
Rank #1016
Market Cap 20.41 B
Volume 448,275
Price 75.35
Change (%) 1.98%
Country or region India India

Divi's Laboratories Limited's latest marketcap:

20.41 B

As of 05/20/2025, Divi's Laboratories Limited's market capitalization has reached $20.41 B. According to our data, Divi's Laboratories Limited is the 1016th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 20.41 B
Revenue (ttm) 1.06 B
Net Income (ttm) 241.49 M
Shares Out 265.47 M
EPS (ttm) 0.91
Forward PE 65.07
Ex-Dividend Date 08/02/2024
Earnings Date 05/23/2025
Market Cap Chart
Data Updated: 05/20/2025

Divi's Laboratories Limited's yearly market capitalization.

Divi's Laboratories Limited has seen its market value grow from ₹1.02 T to ₹1.75 T since 2020, representing a total increase of 71.27% and an annual compound growth rate (CAGR) of 13.06%.
Date Market Cap Change (%)
05/20/2025 ₹1.75 T 2.96%
12/31/2024 ₹1.62 T 56.22%
12/29/2023 ₹1.04 T 14.38%
12/30/2022 ₹906.10 B -27.04%
12/31/2021 ₹1.24 T 21.77%
12/31/2020 ₹1.02 T

Company Profile

About Divi's Laboratories Limited

Divi's Laboratories Limited is a leading manufacturer and supplier of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals. The company operates in India, North America, Asia, Europe, and other international markets.

Products & Services

  • Manufacturing and sale of APIs and intermediates
  • Custom synthesis and contract manufacturing services for APIs and intermediates
  • Nutraceuticals, including carotenoids such as beta carotene, astaxanthin, lycopene, and canthaxanthin
  • Finished forms like lutein and vitamins for food, dietary supplements, and feed industries

Global Presence

The company exports its products worldwide, serving diverse industries with high-quality pharmaceutical and nutraceutical solutions.

Company Background

Originally established as Divi's Research Center in 1990, the company was renamed Divi's Laboratories Limited in 1994. Headquartered in Hyderabad, India, it has grown into a key player in the pharmaceutical and nutraceutical sectors.

Frequently Asked Questions

As of 05/20/2025, Divi's Laboratories Limited (including the parent company, if applicable) has an estimated market capitalization of $20.41 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Divi's Laboratories Limited global market capitalization ranking is approximately 1016 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region India
Founded 1990
IPO Date n/a
Employees 9,741
CEO Kiran Divi
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address Divi Towers
Hyderabad, 500032
India
Website https://www.divislabs.com
People Also Watch
Zoetis
163.94 1.98%
Merck KGaA
130.87 1.98%
Haleon plc
543.32 1.98%
NSE-SUNPHARMA
20.02 1.98%